Well Lead Medical Co., Ltd. (SHA:603309)
China · Delayed Price · Currency is CNY 14.88
0.00 (0.00%)
At close: Jan 23, 2026
Well Lead Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 244.31 | 219.39 | 192.49 | 166.57 | 106.09 | 153.11 | Upgrade |
Depreciation & Amortization | 70.03 | 70.03 | 72.62 | 65.52 | 57.74 | 48.55 | Upgrade |
Other Amortization | 8.47 | 8.47 | 4.32 | 2.61 | 1.62 | 1.09 | Upgrade |
Loss (Gain) From Sale of Assets | -0.43 | -0.43 | -0.09 | -0.04 | -0 | -0.22 | Upgrade |
Asset Writedown & Restructuring Costs | 1.34 | 1.34 | 0.46 | 7.57 | 0.56 | 12.58 | Upgrade |
Loss (Gain) From Sale of Investments | -7.25 | -7.25 | -8.61 | -5.99 | 4.84 | 1.79 | Upgrade |
Provision & Write-off of Bad Debts | 0.21 | 0.21 | 0.79 | -1.4 | 0.83 | 1.78 | Upgrade |
Other Operating Activities | 42.89 | 27.59 | 30.5 | 27.78 | 21.9 | 22.57 | Upgrade |
Change in Accounts Receivable | 14.46 | 14.46 | -74.04 | 59.98 | -20.32 | -3.74 | Upgrade |
Change in Inventory | -34.84 | -34.84 | 8.28 | -5.21 | -36.94 | -31.14 | Upgrade |
Change in Accounts Payable | 5.74 | 5.74 | -6.75 | 52.7 | 50.48 | 21.17 | Upgrade |
Change in Other Net Operating Assets | -4.23 | -4.23 | 2.59 | 21 | 3.22 | - | Upgrade |
Operating Cash Flow | 346.47 | 306.26 | 222.51 | 391.13 | 187.28 | 228.44 | Upgrade |
Operating Cash Flow Growth | 49.26% | 37.64% | -43.11% | 108.84% | -18.02% | 27.77% | Upgrade |
Capital Expenditures | -247.48 | -315.73 | -357.89 | -181.38 | -109.28 | -92.49 | Upgrade |
Sale of Property, Plant & Equipment | 1.99 | 1.93 | 0.34 | 0.08 | 2.94 | 0.5 | Upgrade |
Cash Acquisitions | - | - | - | - | -33.44 | -0.28 | Upgrade |
Divestitures | - | - | - | - | - | -2.64 | Upgrade |
Investment in Securities | 91.5 | 50.89 | 15.19 | -388.31 | -17.16 | -2 | Upgrade |
Other Investing Activities | 4.82 | 7.26 | 17.91 | 9.67 | 0.6 | 1.15 | Upgrade |
Investing Cash Flow | -149.18 | -255.65 | -324.45 | -559.93 | -156.34 | -95.75 | Upgrade |
Long-Term Debt Issued | - | 403.14 | 338.44 | 177.1 | 134.9 | - | Upgrade |
Total Debt Issued | 222.97 | 403.14 | 338.44 | 177.1 | 134.9 | - | Upgrade |
Long-Term Debt Repaid | - | -325.3 | -215.93 | -169.55 | -75.27 | -91 | Upgrade |
Total Debt Repaid | -226.03 | -325.3 | -215.93 | -169.55 | -75.27 | -91 | Upgrade |
Net Debt Issued (Repaid) | -3.06 | 77.85 | 122.51 | 7.56 | 59.63 | -91 | Upgrade |
Issuance of Common Stock | - | - | - | 0.69 | 417.66 | - | Upgrade |
Repurchase of Common Stock | -1.97 | -1.97 | -1.06 | -1.36 | - | - | Upgrade |
Common Dividends Paid | -153.02 | -155.6 | -106.84 | -45.49 | -58.56 | -50.6 | Upgrade |
Other Financing Activities | -9.35 | 12.02 | -2.95 | -8.3 | -4.86 | 3.69 | Upgrade |
Financing Cash Flow | -167.4 | -67.71 | 11.66 | -46.91 | 413.88 | -137.9 | Upgrade |
Foreign Exchange Rate Adjustments | -0.01 | 1.87 | 1.71 | 2.58 | -2.1 | -4.05 | Upgrade |
Net Cash Flow | 29.89 | -15.23 | -88.57 | -213.14 | 442.72 | -9.26 | Upgrade |
Free Cash Flow | 98.99 | -9.47 | -135.38 | 209.75 | 78 | 135.96 | Upgrade |
Free Cash Flow Growth | - | - | - | 168.90% | -42.63% | 105.20% | Upgrade |
Free Cash Flow Margin | 6.04% | -0.63% | -9.75% | 15.38% | 6.97% | 12.02% | Upgrade |
Free Cash Flow Per Share | 0.34 | -0.03 | -0.46 | 0.72 | 0.30 | 0.52 | Upgrade |
Cash Income Tax Paid | 2.76 | 19.13 | 43.92 | 51.41 | 45.9 | 65.82 | Upgrade |
Levered Free Cash Flow | 51.96 | -64.12 | -230.71 | 151.53 | 58.19 | 79.36 | Upgrade |
Unlevered Free Cash Flow | 61.67 | -56.42 | -225.01 | 156.45 | 63.5 | 85.88 | Upgrade |
Change in Working Capital | -13.1 | -13.1 | -69.95 | 128.49 | -6.31 | -12.82 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.